Drugs / GOM-NS
last change Jan 2017 re-read 2 minutes ago

GOM-NS

Developed for
seasonal allergic rhinitis

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02870205 Comparator Aug 2016 → Jan 2017 seasonal allergic rhinitis Glenmark Specialty S.A. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GOM-NS ClinicalTrials.gov intervention name — accepted as the source's own label NCT02870205